Literature DB >> 7172966

Chronic active hepatitis (CAH): criteria for treatment.

E Ascione, C Linardi.   

Abstract

Entities:  

Mesh：

Year:  1982        PMID： 7172966     DOI： 10.1007/bf01391459

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  8 in total

1.  Treatment of chronic active hepatitis. An analysis of three controlled trials.

Authors:  E C Wright; L B Seeff; P D Berk; A Jones; P H Plotz
Journal:  Gastroenterology       Date:  1977-12       Impact factor: 22.682

2.  Controlled trial of prednisone and azathioprine in active chronic hepatitis.

Authors:  I M Murray-Lyon; R B Stern; R Williams
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

3.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

Authors:  R D Soloway; W H Summerskill; A H Baggenstoss; M G Geall; G L Gitnićk; I R Elveback; L J Schoenfield
Journal:  Gastroenterology       Date:  1972-11       Impact factor: 22.682

4.  Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.

Authors:  G C Cook; R Mulligan; S Sherlock
Journal:  Q J Med       Date:  1971-04

Review 5.  Active chronic hepatitis.

Authors:  S P Mistilis; C R Blackburn
Journal:  Am J Med       Date:  1970-04       Impact factor: 4.965

6.  [Immunosuppressive treatment of HBs-antigen positive and negative chronic-active hepatitis (author's transl)].

Authors:  K H Meyer
Journal:  Dtsch Med Wochenschr       Date:  1978-05-26       Impact factor: 0.628

7.  Chronic active hepatitis.

Authors:  M Ponz de Leon; N Carulli
Journal:  Dig Dis Sci       Date:  1981-10       Impact factor: 3.199

8.  Chronic active hepatitis. Who meets treatment criteria?

Authors:  R L Koretz; K J Lewin; J Higgins; N D Fagen; G L Gitnick
Journal:  Dig Dis Sci       Date:  1980-09       Impact factor: 3.199
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.